Medical Supply Business Investment Opportunities

Strategic position in Kuwait City: Operating at the heart of the Gulf, this medical supplies company taps into the thriving healthcare sector in Kuwait City. - Specialization in dental disposables: With dental floss as the top-selling product, the company captures a niche market within the dental disposable products sector. - Diverse product offerings: In addition to dental floss, the company deals in high-demand medical devices such as dental and medical X-ray machines, positioning itself as a versatile player in the medical equipment industry. - Strong clientele base: Serving 6 hospitals, 18 clinics, 18 retail stores, and 3 pharmacy chains, the business has a robust and diverse customer base in the healthcare supply chain. - Prominent dental expertise: The business is led by a seasoned dentist with 19 years of experience, ensuring in-depth industry knowledge and credibility in the marketplace. - Sales have grown significantly as a direct result of effective marketing efforts, which have successfully expanded the customer base and strengthened brand visibility. - Efficient manufacturing partnerships: Outsourcing production to established manufacturers in China and Turkey allows for cost-effective operations while maintaining product quality under the company's trademark. - Trademark and incorporation strength: Holding a trademark and incorporation certificate, the company demonstrates legal stability and brand recognition, crucial for investor confidence and market positioning.

The company is a leading disposable syringe manufacturing plant based in Akola, Maharashtra. - Specializes in producing a range of disposable surgical syringes (2ml, 3ml, 5ml, 10ml), with plans to diversify into IV sets, IV cannulas through third-party manufacturing, enhancing product portfolio. - Boasts a robust distribution network spanning over 4 states with more than 100 distributors and super-stockists, significantly extending its market reach. - The plant operates at a current production capacity of 1 crore syringes per month, with the capability to expand to 1.5 crore units, effectively meeting rising demands. - Complies with MD 5 License, MSME, and GST certifications, underlining a strong commitment to quality standards and regulatory requirements. - Focuses on distributor-based sales strategies, optimizing supply chain efficiency and product availability across various geographies. - Positioned for growth and product diversification within India's growing medical supplies sector, tapping into relevant distribution networks and market opportunities. - It took us around 3–4 months to obtain the necessary government approvals, during which we were unable to manufacture at full capacity or generate significant sales. Now that all required licenses have been secured, we are operating efficiently, leading to a notable increase in our monthly sales.

Located in Vadodara, this wholesale distributor specializes in generic pharmaceuticals and surgical items, catering to healthcare providers and retailers. - A robust network with over 100 pharmacies and clinics alongside 15 years of promoter experience bolsters the company's credibility and market reach. - Top selling category is generic pharmaceuticals, ensuring consistent demand and profitability in the booming generic drug market. - Flexible financial arrangements are provided, with options for one-month credit or immediate cash purchases with discounts, offering attractive conditions for clients. - The company exclusively serves the Baroda district, allowing for focused distribution efforts and a stronger client relationship within the local market. - Compliance is ensured through possession of a CDSCO (Central Drugs Standard Control Organisation) license, essential for operating legally in the Indian wholesale pharmaceutical market. - The ability to achieve yearly sales targets multiple times reflects the company's efficiency and strong demand for its products within the local market.

Located in Vadodara, this wholesale distributor specializes in generic pharmaceuticals and surgical items, catering to healthcare providers and retailers. - A robust network with over 100 pharmacies and clinics alongside 15 years of promoter experience bolsters the company's credibility and market reach. - Top selling category is generic pharmaceuticals, ensuring consistent demand and profitability in the booming generic drug market. - Flexible financial arrangements are provided, with options for one-month credit or immediate cash purchases with discounts, offering attractive conditions for clients. - The company exclusively serves the Baroda district, allowing for focused distribution efforts and a stronger client relationship within the local market. - Compliance is ensured through possession of a CDSCO (Central Drugs Standard Control Organisation) license, essential for operating legally in the Indian wholesale pharmaceutical market. - The ability to achieve yearly sales targets multiple times reflects the company's efficiency and strong demand for its products within the local market.

Revenue model: Margin from products. - Team: Led by industry veterans. - Customers: 120+ premium B2B customers. - Running successfully for the last 5 plus years with steady growth. - 40% of the revenue is generated by selling medical equipment and 60% is generated by selling medicines. - We work with healthcare non-profits to strengthen the health of their organization, helping them control costs, develop efficiencies and enhance quality. - We act as a centralized sourcing and distributing partner focused on servicing medical product needs for medical organizations. - The business possesses Drug, PCPNDT, food and export licenses. - The revenue has significantly increased this year since we have onboarded new customers.

Established over a decade ago, the company is strategically positioned in the Subic Bay Freeport Zone, enhancing its trade efficacy in the Philippines. - Engages in a myriad of product lines, with a focus on medical supplies, office essentials, and personal protective equipment, catering to diverse customer needs. - Boasts a strong clientele base comprising 30 key clients, including manufacturers, hospitality establishments, the Philippine police, the Philippine government, hospitals, and corporations. - Operates with a lean workforce of 20 employees, and additional hires agencies, and contractual workers for optimizing operational efficiency while serving a broad array of sectors. - Expands product portfolio beyond medical and office supplies, including uniforms, cleaning agents, rescue supplies, service vehicles, and grocery items. - Central location in Olongapo facilitates robust logistics and supply chain operations within the Freeport Zone. - Successfully serves critical sectors such as healthcare and law enforcement, demonstrating industry versatility and market adaptability.

Accredited with all the required certifications like CE- MDR, US FDA, CE PPE, ISO 13485, ISO 9001: 2016 and sedex certified for ethical manufacturing. - Ours is one of the 3 companies with a CE MDR in India at present which is the latest regulation for CE. - In India we have the 4th largest production capacity catering to 8 countries in Europe, 3 countries in Latin America, 8 countries in Africa and 7 in Asia respectively. - We are also the contract manufacturers for a popular company with a monthly sales of 15 lakhs pairs. - In a month, we can produce about 1 crore pairs of gloves.

The company is an established player in the market with a strong track record of manufacturing ICU products such as oxygen masks, ventilators, nebulization masks, ECG gel, and ultrasound gel under their own brand. - The promoter, a microbiologist with over 30 years of experience in marketing pharmaceuticals, nutraceuticals, and medical devices, is now venturing into sterile pharmaceutical manufacturing in their existing facility in Ahmedabad and is seeking funding for the same. - The company is planning to diversify its product line by entering the eye drops manufacturing and marketing segment, leveraging its existing network of 14 distributors across India. - With the intention to comply with new government regulations, the company plans to shift its focus from manufacturing pharmaceutical products with a focus on eye drops, while outsourcing the production of medical devices to third-party manufacturers. - Production of the pharmaceutical products is set to start within four to six months, ensuring quick returns. - The company is currently concentrating on B2B sales with a vision to establish its own dedicated sales team supported by a distributor network. - Notable end users of the company's products include reputable names such as Shelby Hospital and the Apollo Group. - The company has a cosmetic license and FSSAI license and is in the process of acquiring the FDCA for drug manufacturing. - The company is registered in Delhi but the facility is located near Changodar, Ahmedabad which is one of India's biggest pharma-manufacturing hubs. - Our valuation is a product of the expected turnover of INR 1 Crore that we will achieve once the new venture starts.

Our company is a pre-revenue start-up, at an advanced stage of product launch targeting the TOP 20 companies in the field of consumer healthcare products.

Medical supplies and lab services company offering a wide range of services including testing for blood and urine. - Comprehensive range of medical and surgical supplies available, including lab equipment, wheelchairs, and ancillary supplies for both end consumers and hospitals. - Franchise of a renowned brand, ensuring quality and reliability in lab services. - Servicing over 1,000 clients in both retail and wholesale sectors. - Presence in Kannur with 2 branches catering to local demand. - Specialization in primary medical supplies within the two verticals. - Promoters bring 20 years of experience in the industry, ensuring expertise and reliability. - Fully licensed and compliant with necessary regulations including drug license, lab license, GST, and incorporation.

This investment presents an opportunity for early-stage involvement in a high-growth pharmaceutical company with an established market presence. This investment will support us in achieving its ambitious growth plans, maximizing returns while strengthening our position as a leading provider in Malaysia’s pharmaceutical industry.